(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202203 | 202103 | % Var | 202203 | 202103 | % Var | 202203 | 202103 | % Var | |
| Sales | 29466.10 | 26442.00 | 11.44 | 130917.90 | 113027.10 | 15.83 | 130917.90 | 113027.10 | 15.83 |
| Other Income | 3163.10 | 493.30 | 541.21 | 6667.00 | 2302.80 | 189.52 | 6667.00 | 2302.80 | 189.52 |
| PBIDT | 7039.60 | 6875.80 | 2.38 | 40331.70 | 32976.90 | 22.30 | 40331.70 | 32976.90 | 22.30 |
| Interest | 57.80 | 88.40 | -34.62 | 269.30 | 450.70 | -40.25 | 269.30 | 450.70 | -40.25 |
| PBDT | 6981.80 | 6787.40 | 2.86 | 40062.40 | 32526.20 | 23.17 | 40062.40 | 32526.20 | 23.17 |
| Depreciation | 1168.20 | 1177.50 | -0.79 | 4600.10 | 4686.20 | -1.84 | 4600.10 | 4686.20 | -1.84 |
| PBT | 5813.60 | 5609.90 | 3.63 | 35462.30 | 27840.00 | 27.38 | 35462.30 | 27840.00 | 27.38 |
| TAX | 1050.60 | 1413.30 | -25.66 | 8568.40 | 7393.50 | 15.89 | 8568.40 | 7393.50 | 15.89 |
| Deferred Tax | -35.00 | 92.80 | -137.72 | -304.00 | -169.20 | 79.67 | -304.00 | -169.20 | 79.67 |
| PAT | 4763.00 | 4196.60 | 13.50 | 26893.90 | 20446.50 | 31.53 | 26893.90 | 20446.50 | 31.53 |
| Equity | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 |
| PBIDTM(%) | 23.89 | 26.00 | -8.13 | 30.81 | 29.18 | 5.59 | 30.81 | 29.18 | 5.59 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.50 |
| Dr. Reddys Lab | 1236.80 |
| Cipla | 1234.00 |
| Zydus Lifesciences | 938.50 |
| Lupin | 2323.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: